Science Explorer Interactive view Map

Agenta Biotechnologies (United States)

Research works
4
▼ 60% vs 2013–17
Citations
127
34.0 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
81%
world 28%

Not ranked overall: Agenta Biotechnologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Agenta Biotechnologies (United States) publish most on?

By volume in 2022–2025: vaccines and immunoinformatics approaches, Pneumonia and Respiratory Infections and Bacterial Infections and Vaccines.

  1. 1 vaccines and immunoinformatics approaches Molecular Biology 0 works
  2. 2 Pneumonia and Respiratory Infections Epidemiology 0 works
  3. 3 Bacterial Infections and Vaccines Microbiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.2%not open18.8%

World: 28% of research is openly available.

with international co-authors61.2%domestic only38.8%

World: 19% is written across borders.

How has Agenta Biotechnologies (United States)'s research output changed?

Output in 2018–2022 was 60% lower than in 2013–2017.

200520102015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Birmingham

All research institutions in Birmingham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.